Streetbeat News

Regulatory

BTCY

Biotricity has regained compliance with Nasdaq listing requirements.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:03 pm

NVCR

Novocure has received a positive recommendation from an independent data monitoring committee to continue its Phase 3 PANOVA-3 trial. The trial is evaluating the effectiveness of Tumor Treating Fields Therapy in treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:02 pm

BGNE

BeiGene (NASDAQ:BGNE) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommending approval for tislelizumab as a treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC).

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:58 am

MRK

Merck (NYSE:MRK) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for gefapixant, a non-narcotic oral selective P2X3 receptor antagonist developed for the treatment of adults with chronic cough. The recommendation will be reviewed by the European Commission for marketing authorization in the EU, with a final decision expected later this year.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:53 am

PFE

VGK

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Pfizer's Litfulo (Ritlecitinib) for the treatment of severe alopecia areata.

Portfolio Pulse from Charles Gross

July 21, 2023 | 11:52 am

BABA

FXI

KWEB

Alibaba Group Holding Limited (NASDAQ:BABA) stock is trading higher following China's 31-point plan to provide more robust support for private firms. The plan addresses issues like market entry, fair competition, financing support, payment defaults, intellectual property rights, and legal protection. Alibaba is also focusing on its generative AI endeavors and organizational restructuring to unlock higher shareholder value. Chinese ETFs IShares China Large-Cap ETF (NYSE:FXI) and KraneShares Trust KraneShares CSI China Internet ETF (NYSE:KWEB) are also trading higher.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 11:48 am

RDHL

RedHill Biopharma has announced additional U.S. Government funding for the development of Opaganib nuclear countermeasure. This news has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:45 am

BRTX

BioRestorative Therapies has received a license from the New York State Department of Health to operate as a tissue bank. This license allows the company to process mesenchymal stem cells obtained from autologous donors.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:14 am

BMY

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended approval of Bristol Myers Squibb's Opdivo (Nivolumab) as a monotherapy for the adjuvant treatment of adults and adolescents with completely resected stage IIB or IIA melanoma.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 11:02 am

BTCUSD

COIN

ETHUSD

Coinbase has announced that it will fully shut down its Borrow Lending Program in November. This comes after the company faced regulatory scrutiny from the SEC over the program.

Portfolio Pulse from Charles Gross

July 21, 2023 | 10:33 am